Skip to content
naftopidil

Structure via PubChem · Public domain (PubChem)

EntityQ6958243· pop 6· linked from 985 articles

naftopidil

Sign in to save

Naftopidil (INN, marketed under the brand name Flivas) is a drug used in benign prostatic hyperplasia which acts as a selective α1-adrenergic receptor antagonist or alpha-1 blocker.

In the Vinony graph

Vinony's link graph records 985 inbound references to naftopidil, and connects out to propranolol, atenolol and adrenergic receptor.

It is catalogued under topics including 2-Methoxyphenyl compounds, Alpha-1 blockers and Antihypertensive agents.

Vinony links it to 5 Wikipedia language editions.

Chemical data

Formula
C24H28N2O3
Molecular weight
392.5 g/mol
IUPAC name
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol
SMILES
COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O
InChIKey
HRRBJVNMSRJFHQ-UHFFFAOYSA-N
XLogP
4.1
Polar surface area
45.2 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1999
Admin. routes
oral
Indications
hyperplasia

via ChEMBL · EBI

Wikidata facts

Mass
392.21
Show 4 more facts
chemical formula
C₂₄H₂₈N₂O₃
canonical SMILES
COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O
Commons category
Naftopidil
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

3 sections
Contents
  • Synthesis
  • See also
  • References

Naftopidil (INN, marketed under the brand name Flivas) is a drug used in benign prostatic hyperplasia which acts as a selective α1-adrenergic receptor antagonist or alpha-1 blocker.

==Synthesis== upright=2|class=skin-invert-image

Excerpted from Wikipedia’s “naftopidil” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0

Connections

Categories